Anesthesiology Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-Sen University, Guangzhou, China; Department of Oncology, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan, China.
Phytomedicine. 2018 Sep 15;48:129-140. doi: 10.1016/j.phymed.2018.04.045. Epub 2018 Apr 17.
Pathological pain conditions can be triggered after peripheral nerve injury and/or inflammation. It is a major clinical problem that is poorly treated with available therapeutics. Curcumin is a phenolic compound derived from Curcuma longa, being widely used for its antioxidant, anti-inflammatory and immunomodulatory effects.
This review systematically summarized updated information on the traditional uses of curcumin in order to explore antinociceptive effects in pathological pain and evaluate future therapeutic opportunities clinically. Moreover, some structure-activity relationships would greatly enrich the opportunity of finding new and promising lead compounds and promote the reasonable development of curcumin.
PubMed were searched and the literature from the year 1976 to January 2018 was retrieved using keywords pain and curcumin.
This review systematically summarized updated information on the traditional uses, chemical constituents and bioactivities of curcumin, and highlights the recent development of the mechanisms of curcumin in the pathological pain by sciatic nerve injury, spinal cord injury, diabetic neuropathy, alcoholic neuropathy, chemotherapy induced peripheral neuroinflammtion, complete Freund's adjuvant (CFA) injection or carrageenan injection. Importantly, the clinical studies provide a compelling justification for its use as a dietary adjunct for pain relief. And we also present multiple approaches to improve bioavailability of curcumin for the treatment of pathological pain.
This review focuses on pre-clinical and clinical studies in the treatment of pathological pain. Although the mechanisms of pain mitigating effects are not very clear, there is compelling evidence proved that curcumin plays an essential role. However, further high-quality clinical studies should be undertaken to establish the clinical effectiveness of curcumin in patients suffering from pathological pain. Potential methods of increase the water solubility and bioavailability of curcumin still need to be studied. These approaches will help in establishing it as remedy for pathological pain.
病理性疼痛可在外周神经损伤和/或炎症后引发。这是一种临床治疗效果很差的主要问题。姜黄素是一种来源于姜黄的酚类化合物,由于其抗氧化、抗炎和免疫调节作用而被广泛使用。
本文系统总结了姜黄传统用途的最新信息,旨在探讨其在病理性疼痛中的镇痛作用,并评估其在临床上的未来治疗机会。此外,一些构效关系将极大地丰富寻找新的有前途的先导化合物的机会,并促进姜黄的合理开发。
通过关键词“疼痛”和“姜黄素”在 PubMed 上进行检索,并检索了 1976 年至 2018 年 1 月的文献。
本文系统总结了姜黄传统用途、化学成分和生物活性的最新信息,重点介绍了姜黄在坐骨神经损伤、脊髓损伤、糖尿病神经病变、酒精性神经病、化疗诱导的周围神经炎症、完全弗氏佐剂(CFA)注射或角叉菜胶注射等病理性疼痛模型中的作用机制的最新进展。重要的是,临床研究为其作为缓解疼痛的饮食辅助剂的应用提供了有力的依据。我们还提出了多种方法来提高姜黄素治疗病理性疼痛的生物利用度。
本文重点关注病理性疼痛治疗的临床前和临床研究。尽管其镇痛作用的机制尚不清楚,但有确凿的证据表明姜黄素发挥了重要作用。然而,仍需要进行更多高质量的临床研究,以确定姜黄素治疗病理性疼痛患者的临床疗效。提高姜黄素水溶性和生物利用度的潜在方法仍需研究。这些方法将有助于将其确立为病理性疼痛的治疗方法。